Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Eisaku Yoden is active.

Publication


Featured researches published by Eisaku Yoden.


BJUI | 2012

Salvage high-dose-rate brachytherapy for local prostate cancer recurrence after radiotherapy – preliminary results

Yoshimasa Jo; Tomohiro Fujii; Ryoei Hara; Teruhiko Yokoyama; Yoshiyuki Miyaji; Eisaku Yoden; Junichi Hiratsuka; Atsushi Nagai

Study Type – Prognostic (case series)


Journal of Radiation Research | 2011

Radiation Therapy in Patients with Implanted Cardiac Pacemakers and Implantable Cardioverter Defibrillators: A Prospective Survey in Japan

Toshinori Soejima; Eisaku Yoden; Yasumasa Nishimura; Seiji Ono; Akihiro Yoshida; Haruyuki Fukuda; Noboru Fukuhara; Ryohei Sasaki; Kayoko Tsujino; Yoshiki Norihisa

Radiotherapy/Pacemaker/ICD/Malfunction. Patients with implanted cardiac pacemakers (ICPs) or implantable cardioverter defibrillators (ICDs) ar e increasing in number, and the incidence of treating these patients with radiation therapy also is increasing. Thus, a prospective survey was conducted of patien ts with these devices receiving radiation therapy. A prospective survey of patients with ICPs or ICDs treated with radiation therapy was conducted on methods of radiation therapy, status of ICP/ICD, and management of patients before, during, and after radiation th erapy. After completion of radiation therapy, study participants were registered via mail, fax, or e-mail. Sixty-two patients from 29 institutions were registered from September 2006 to December 2008. Sixty patients had an ICP and 2 had an ICD. The total dose was estimated before radiation therapy by dosevolume histogram in 26 patients (42%) and by measurement of actual doses in 9 (15%). In one patient, the maximum total dose was 2069 cGy; however, in the other patients, the ICP/ICD dose did not exceed 478 cGy. Function of ICPs and ICDs was checked before radiation therapy in 38 patients (61%), after radiation therapy in 32 (52%), and both before and after radiation ther apy in 29 (47%). ICP malfunction occurred in a patient with prostate cancer treated by intensity-modulated radiation therapy to the prostate. Even when an ICP or ICD is not within the field of radiation, malfunction of the device may still occur. To minimize the risk to patients, precautions must be taken during the planning and administration of radiation therapy.


International Journal of Clinical Oncology | 2002

A long-term survivor of leiomyosarcoma around the right side of the base of the skull: effective radiotherapy combined with intra-arterial chemotherapy.

Ryoji Tokiya; Yoshinari Imajo; Eisaku Yoden; Junichi Hiratsuka; Makito Kobatake; Masayuki Gyoten; Shigeki Imai; Yasumasa Kajihara

Abstract We report a rare case of a leiomyosarcoma that developed around the right side of the base of the skull in a 51-year-old woman. The patient consulted our hospital complaining of pain in the right side of her neck and upper right arm in August 1994. A leiomyosarcoma, originating around the right side of the neck and base of the skull was diagnosed. Initially, surgery was planned, but invasion into the spinal canal was discovered. Curative resection of the leiomyosarcoma around the right side of the base of the skull was not possible. Therefore, external beam radiotherapy (EBRT) combined with intra-arterial chemotherapy and hyperthermia was employed. After the treatment, the tumor decreased in size to 45% of its initial volume, and, simultaneously, her symptoms completely disappeared. The patient initially remained clinically free of the disease, but showed reaggravations at the primary tumor site 3 years and 3 months, and 4 years and 11 months, after the first treatment. The reaggravations were treated with EBRT combined with intra-arterial chemotherapy. As a result, she survived for 5 years and 7 months after the first treatment.


International Journal of Oral and Maxillofacial Surgery | 1999

High dose rate Microselectron mould radiotherapy of a widespread superficial oral cancer

Eisaku Yoden; Junichi Hiratsuka; Yoshinari Imajo; Tsuyoshi Hata; Masaru Hosoda

Treatment of a case of widespread superficial oral squamous cell carcinoma with external beam irradiation, followed by high dose rate Microselectron mould radiotherapy, is reported. The tumor disappeared macroscopically after treatment, but there was infield recurrence in the buccogingival sulcus where the radiation dose might have been inadequate. Apart from some radiation mucositis within the treated area, edema and a superficial ulcer were observed in the tongue. These were considered to be due to radiation overdose. Although there is room for improvement, this mode of treatment has something to offer patients with hard-to-cure cancer.


International Journal of Clinical Oncology | 2000

Lung adenosquamous carcinoma with lingual and cardiac metastases

Eisaku Yoden; Masami Iizuka; Hiroyo Deguchi; Takashi Fukuya; Yoshinari Imajo; Junichi Hiratsuka; Masaru Hosoda; Hiroshi Namio; Hiroshi Toyoda

Abstract Metastatic lingual tumors are very rare, and hematogenous myocardial metastasis is also relatively uncommon. We report a case of lung adenosquamous carcinoma with metastases to the tongue and the myocardium. A 65-year-old man underwent a partial upper lobectomy for a primary lung cancer in June 1997. He developed a local recurrence and received two courses of radiotherapy, in March and September 1998. A follow-up computed tomography (CT) scan showed a myocardial tumor, suggestive of cardiac metastasis. In October 1998, he began to complain of angina-like chest oppression and showed ischemic changes on electrocardiogram (ECG), and he also developed lingual, subcutaneous, and brain metastases. He died of respiratory failure in December 1998, 20 months after the initial diagnosis of primary lung cancer; metastases to the tongue and myocardium were confirmed by autopsy.


Journal of Contemporary Brachytherapy | 2018

Case report of a dose-volume histogram analysis of rib fracture after accelerated partial breast irradiation: interim analysis of a Japanese prospective multi-institutional feasibility study

Ken Yoshida; Yuki Otani; Takayuki Nose; Eisaku Yoden; Shuuji Asahi; Iwao Tsukiyama; Takushi Dokiya; Toshiaki Saeki; Ichirou Fukuda; Hiroshi Sekine; Yu Kumazaki; Takao Takahashi; Tadayuki Kotsuma; Norikazu Masuda; Kazutaka Nakashima; Taisei Matsumura; Shino Nakagawa; Seiji Tachiiri; Yoshio Moriguchi; Jun Itami; Masahiko Oguchi

We initiated the first multi-institutional prospective study of accelerated partial breast irradiation for early breast cancer in Japan. Our early clinical results showed that the treatment methods were technically reproducible between institutions and showed excellent disease control at a median follow-up of 26 months in our previous report. At present, total 46 patients from six institutions underwent the treatment regimen from October 2009 to December 2011, and the median follow-up time was 60 months (range, 57-67 months). In 46 patients, we experienced one patient who had rib fracture as a late complication. The dose-volume histogram (DVH) result of this patient was analyzed. The D0.01cc, D0.1cc, and D1cc values of the patient were 913, 817, and 664 cGy per fraction, respectively. These values were the highest values in 46 patients. The average D0.01cc, D0.1cc, and D1cc values of the other 45 patients were 546, 500, and 419, respectively, cGy per fraction. From this result, DVH values showing high-dose irradiated volume (D0.01cc, D0.1cc, and D1cc) seem to be a good predictive factor of rib fracture for accelerated partial breast irradiation. However, further investigation is necessary because of the small number of patients investigated.


Breast Cancer | 2000

Interstitial Brachytherapy for Recurrent Breast Cancer Using a High Dose Rate Ir-192 Remote Afterloading System: A Report of Two Cases

Eisaku Yoden; Junichi Hiratsuka; Yoshinari Imajo; Shigeru Yamamoto; Junichi Kurebayashi; Koujiro Shimozuma; Hiroshi Sonoo

We employed interstitial brachytherapy using a high dose rate lr-192 remote afterloading unit in two breast cancer patients with locoregional recurrence. In the first case, skin metastasis was treated, with favorable control of the infield tumor but subsequent persistent sequelae and multiple outfield metastases. This experience caused us to be cautious when choosing brachytherapy for the second case, in whom a solitary metastasis to an axillary lymph node was successfully treated. Although this method is still investigational, it may play a critical role in the treatment of locoregional recurrence resistant to other treatment modalities.


International Journal of Gynecological Cancer | 2002

Local radiation therapy for localized relapsed or refractory ovarian cancer patients with or without symptoms after chemotherapy

Keiichi Fujiwara; Sachiko Suzuki; Eisaku Yoden; Hiroyasu Ishikawa; Yoshinari Imajo; Ichiro Kohno


Breast Cancer | 2008

Whole-breast radiotherapy with shorter fractionation schedules following breast-conserving surgery: short-term morbidity and preliminary outcomes

Osamu Fujii; Jyunichi Hiratsuka; Naomi Nagase; Ryuji Tokiya; Eisaku Yoden; Hiroshi Sonoo; Nobutaka Murashima; Shigemichi Iha; Yoshinari Imajyo


Gynecologic Oncology | 2000

Negative MRI Findings with Invasive Cervical Biopsy May Indicate Stage IA Cervical Carcinoma

Keiichi Fujiwara; Eisaku Yoden; T. Asakawa; Michio Shimizu; Mitsuyoshi Hirokawa; Yoshiki Mikami; Takashi Oda; Ikuo Joja; Yoshinari Imajo; Ichiro Kohno

Collaboration


Dive into the Eisaku Yoden's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hiroshi Sekine

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Masahiko Oguchi

Japanese Foundation for Cancer Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge